See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
No Insider Transactions found for ONCOLYTICS BIOTECH INC
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Mar 12, 2026 Kelly Jared |
Kelly Jared
CEO
|
Buy |
5,050 | $0.96 | 5,050 $0.96 $4,848 |
Mar 11, 2026 Parsons James T. |
Parsons James T.
|
Buy |
10,000 | $1.03 | 10,000 $1.03 $10,300 |
Feb 12, 2026 Andrews Patricia S |
Andrews Patricia S
|
Buy |
35,400 | $0.86 | 35,400 $0.86 $30,292 |
Feb 12, 2026 Pisano Wayne |
Pisano Wayne
|
Buy |
30,000 | $0.84 | 30,000 $0.84 $25,338 |
Feb 12, 2026 Seizinger Bernd R. |
Seizinger Bernd R.
|
Buy |
40,000 | $0.85 | 40,000 $0.85 $33,864 |
Feb 12, 2026 Look Kirk |
Look Kirk
CFO
|
Buy |
12,000 | $0.84 | 12,000 $0.84 $10,104 |
Feb 12, 2026 Kelly Jared |
Kelly Jared
CEO
|
Buy |
29,500 | $0.84 | 29,500 $0.84 $24,839 |
Feb 12, 2026 Hagerman Allison |
Hagerman Allison
VP, Product Development
|
Buy |
10,000 | $0.83 | 10,000 $0.83 $8,298 |
Feb 12, 2026 Heineman Thomas Charles |
Heineman Thomas Charles
CMO
|
Buy |
12,132 | $0.83 | 12,132 $0.83 $10,033 |
Feb 12, 2026 Brown Deborah Margaret |
Brown Deborah Margaret
|
Buy |
25,000 | $0.85 | 25,000 $0.85 $21,240 |
Feb 11, 2026 Seizinger Bernd R. |
Seizinger Bernd R.
|
Buy |
60,000 | $0.83 | 60,000 $0.83 $49,590 |
Feb 11, 2026 Aromando Andrew |
Aromando Andrew
CBO
|
Buy |
29,600 | $0.86 | 29,600 $0.86 $25,418 |
Feb 11, 2026 Kelly Jared |
Kelly Jared
CEO
|
Buy |
5,600 | $0.84 | 5,600 $0.84 $4,682 |
Jan 16, 2026 Seizinger Bernd R. |
Seizinger Bernd R.
|
Buy |
100,000 | $1.04 | 100,000 $1.04 $103,770 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
No Historical Insider Transactions found for ONCOLYTICS BIOTECH INC
TOP
